Pharmaceutical Industry
Ireland's pharmaceuticals industry a target for US tariffs - BBC.com
Trump Weighs Tariffs on Ireland’s Pharma Industry. How to Play the Sector. - Barron's
Trump to announce pharma tariffs soon - The Economic Times
Tariff treatment: Six diagnoses for EU pharma sector amid US trade war - Euronews
Will pharmaceutical tariffs achieve their goals? - Brookings Institution
Trump threatens the Fighting Irish with targeted pharma tariffs. Game on? - EURACTIV
Digital Therapeutics Companies: A Guide for Pharma - Pharmaceutical Technology
Donald Trump says he is willing to cut deals on reciprocal tariffs, may soon target pharmaceutical industry - Mint
Drugs Licensed
Prescription Drug Costs | Pros, Cons, Debate, Arguments, Economy, Laws, Government, & Regulation - Britannica
Novo Nordisk to license obesity drug from Lexicon in up to $1 billion deal - Reuters.com
Another Ohio beauty spa loses license over bootleg drug allegations - Ohio Capital Journal
Pharmacist accused of theft, addiction, and working while impaired wins back license - Iowa Capital Dispatch
Cherry Hill doctor forfeits his medical license amid drug charges - Courier Post
IONS Out-Licenses ex-U.S. Rights for Rare Disease Drug Tryngolza to Sobi - Yahoo Finance
Compound versions of some weight loss drugs to be restricted - ABC News
Proposed legislation paves the way for AI to prescribe drugs - Mobihealth News
A new biotech licensing Chinese drugs with a unique approach gets high-profile backing - STAT
Drugs Patents
8 key drug patents expiring soon — and what it means for the market - Quartz
Proposed Bills Limit Pharmaceutical Patents: Panacea for Patients or Poison for Pharmaceutical Producers? - Crowell & Moring LLP
US Patent Office grants Closed Loop Medicine key patents for cardiometabolic capabilities in GLP-1 and Direct Oral Anti-Coagulants (DOAC) therapies - News-Medical.Net
Merck lays out subcutaneous Keytruda data in lung cancer amid patent brawl with Halozyme - FiercePharma
Revolutionary Fingerprint Drug Test Secures Game-Changing Patent for 2025 US Launch - StockTitan
US patent granted for INBS’ fingerprint drug screening technology - Medical Device Network
Sponsored Content: The Connection Between Patents and High Drug Prices - POLITICO
Just How Steep Is the Drug Patent Cliff? Ask These Pharmas - BioSpace
USPTO Confirms Unreliable Patent Numbers by I-MAK in Drug Pricing Debate - Hudson Institute
Drugs Generics
Generic Tofacitinib and the Future of Expensive Generics - Medscape
Did you overpay for generic drugs? Here’s how NJ residents can check - New Jersey 101.5 FM
Will pharmaceutical tariffs achieve their goals? - Brookings Institution
Find out if you're eligible for compensation in $39.1M generic drug price-fixing settlement - KTNV 13 Action News Las Vegas
All generic drugs are not equal, study finds - The Ohio State University News
AG Yost Secures $49.1 Million Settlement in Generic Drug Price-Fixing Case - Scioto Post
Clearing the Path for New Uses for Generic Drugs - Federation of American Scientists
What Is a Generic Drug? - Health Essentials
RAI Explainer: Generic Drugs, Property Rights, and the Orange Book - Center for Strategic & International Studies
FDA Food and Drug Administration
Good Machine Learning Practice for Medical Device Development: Guiding Principles - FDA.gov
'There will be slowdowns': How RFK's health department cuts will affect you - USA TODAY
The top FDA vaccine official is forced out, cites RFK Jr.'s 'misinformation and lies' - NPR
Top vaccine official Peter Marks forced out at FDA, WSJ reports - Reuters
Constituent Update - FDA.gov
Top vaccine official forced out of FDA - CNN
FDA Announces a “Chemical Contaminants Transparency Tool” to Evaluate Potential Health Risks of Contaminants in Human Foods. - The National Law Review
FDA to staff: No need to work from pantries for now - STAT
FDA's top vaccine official forced out, decries RFK Jr.'s "misinformation and lies" - CBS News
Pharmaceutical Companies
Ireland's pharmaceuticals industry a target for US tariffs - BBC.com
Tariff treatment: Six diagnoses for EU pharma sector amid US trade war - Euronews
Trump to announce pharma tariffs soon - The Economic Times
Senate investigation claims Pfizer shifted profits offshore in what could be pharma's 'largest tax-dodging scheme' - FiercePharma
Pharma R&D Returns Grow Again, But Deloitte Warns Progress is ‘Fragile’ - BioSpace
AbbVie, J&J to add proprietary data to AI protein model in bid to accelerate drug discovery - STAT
Trump threatens the Fighting Irish with targeted pharma tariffs. Game on? - EURACTIV
StockWatch: Will Trump Tariffs Return Biopharma Manufacturing to the U.S.? - Genetic Engineering & Biotechnology News
Curium Pharma Acquires Monrol - Contract Pharma
Retail Pharmacies
Novo Nordisk Extends Lowered Wegovy Price to Retail Pharmacies - Managed Healthcare Executive
Independent pharmacists urge lawmakers to adopt PBM bill - Indiana Capital Chronicle
Independent pharmacy opens in Washington Square, offering alternative to crowded chain stores - Brookline.News
Nearly 1 in 3 retail pharmacies have closed since 2010 - UC Berkeley School of Public Health
Novo Nordisk offers cheaper Wegovy for all cash-paying patients at retail pharmacy - FiercePharma
Did You Know: UConn Health Offers Retail Pharmacy Services? - University of Connecticut
Novo Nordisk Wegovy savings offer expanded to all retail pharmacies (NVO:NYSE) - Seeking Alpha
Filling a prescription in the Seattle area? Put on comfortable shoes and be ready to wait - The Seattle Times
Novo Nordisk Wegovy savings offer expanded to all retail pharmacies - MSN
Drug Marketing
Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case - CNBC
European committee says Lilly Alzheimer's drug shouldn't get marketing approval - Yahoo Finance
Prescription Drug Costs | Pros, Cons, Debate, Arguments, Economy, Laws, Government, & Regulation - Britannica
Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case - MSN
J&J unit ordered to pay $1.64B in HIV drug marketing case, Reuters reports - TipRanks
China Releases Draft Implementation Measures for the Protection of Drug Trial Data Including Data Exclusivity for Foreign-Originated Drugs - The National Law Review
Johnson & Johnson Unit Ordered to Pay US About $1.64 Billion in HIV Drug Marketing Case - Marketscreener.com
EU Drug Market: MDMA — In-depth analysis - euda.europa.eu
Merck plans to launch US subcutaneous version of Keytruda on October 1 - Reuters.com